Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Quantifying Endotoxins Via Absorbance Or Fluorescence
Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.
-
Can Collaboration Close Biopharma's Talent Gap For Good?
Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.
-
If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?
Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?
-
Industry Innovators: APAC's Sharp Advanced Therapeutics Edge
APAC is rapidly advancing its role in the global therapeutics landscape, fueled by faster development models. Learn how this momentum is reshaping expectations for innovation and commercialization.
-
Patented Process For Intermediates Useful For Etrasimod Arginine
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
High-Throughput Pyrogen Testing In A Multimode Microplate Reader
Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.
-
Method Development For Forced Degradation Of GLP-1 Agonist
Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
-
Denaturing SEC-MS Analysis Of High Molecular Weight Impurities
Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.
-
Enhancing Drug Performance Through Lipid-Based Formulations For CNS Indication
Advance CNS-penetrant therapies by optimizing oral formulations to improve bioavailability, stabilize the API, and deliver more consistent and reliable drug exposure.
-
ddPCR Workflows For Gene Expression Analysis
RT-ddPCR offers a powerful, flexible approach to precise RNA quantification. Learn how one-step and two-step workflows improve sensitivity and efficiency in your gene expression studies.
FORMULATION DEVELOPMENT SOLUTIONS
- Trusted End-To-End CDMO Partner For Your Journey
- R&D And Analytical Services
- Granulated Materials: Easy Handling For Improved Process Efficiency
- High-Content Screening System
- Comprehensive ADC And Bioconjugation Services For Targeted Therapies
- A High-Purity Excipient Suitable For High-Risk Vaccine Applications
- Peptide Development Strategies
- Developing Palatable, Age Appropriate Drug Products
- API Stability Combined With Rapid Disintegration
- Flow Process Technology
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- TerraPower Isotopes Announces Plans To Build New cGMP Drug Manufacturing Facility In Philadelphia
- Experience Safer Pharmaceutical Processing With Esco Lifesciences At INTERPHEX 2026
- Discover Safer, Smarter Pharmaceutical Processing With Esco Lifesciences
- Axplora Announces $60 Million High Potency API Manufacturing Facility Expansion In Italy
- METTLER TOLEDO Launches New eGuide To Help Food Manufacturers Prevent Physical Contamination
- BD Announces $110 Million To Support U.S. Pharmaceutical Supply Chain For Biologic Drugs
- BD And Ypsomed Expand Partnership To Address Rapidly Growing Biologics Market
- ROSS PDDM-10 Planetary Dual Disperser Delivers Unmatched Pilot-Scale Processing Flexibility
- Emerson Streamlines Life Sciences Recipe Creation For Faster Time To Market
- Forma Life Sciences Launches U.S. Based Contract Development And Manufacturing Organization (CDMO) For Oral Solid Dosage Development And Commercial Manufacturing In Irvine, California